ReviewMolecular pharmaceutics

Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.

Virginia M Platt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.